Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJG62
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $83,345
Award facts
- Contract value 100% obligated
- $83,344.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $83,344.67 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors on August 6, 2025. This firm fixed-price delivery order, which is not subject to any small business set-aside designation, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with a completion deadline of August 7, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, fulfills this order under its larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026.
This delivery order represents a routine pharmaceutical supply transaction supporting military and federal healthcare systems. Dupixent (dupilumab) is a prescription biologic medication used for treating eczema, asthma, and other inflammatory conditions. As a child delivery order under the comprehensive DLA Troop Support Medical IDC, this award reflects AmerisourceBergen Drug Corp's established role as a prime pharmaceutical vendor supplying specialty medications and brand-name drugs to support defense healthcare programs worldwide. The competitive, non-set-aside procurement structure and firm fixed pricing demonstrate the contractor's ability to deliver specialized pharmaceutical products efficiently within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJG62?
SPE2DB25FJG62 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FJG62 worth?
The government has obligated $83,345 on SPE2DB25FJG62.
Is contract SPE2DB25FJG62 an order under another contract?
Yes. SPE2DB25FJG62 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG62 competed?
The extent of competition for SPE2DB25FJG62 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award